Preclinical stage biotech company that is developing selective pathogenic T-cell depleters using proprietary bispecific antibodies
EnRosa Therapeutics
Immunology
Total Addressable Market
Red Tree Board Member(s)
Red Tree Board Members
Heath Lukatch, Ph.D.
Jeremy Caldwell, Ph.D.
Deborah Nguyen, Ph.D.
Affiliated with Red Tree SAB Member
Red Tree Venture Labs company creation
Red Tree Participation
Led seed round